Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 676
Appendix
C
Committee to Review the Health Effects
in Vietnam Veterans of Exposure
to Herbicides (Seventh Biennial
Update) and Staff Biographies
Richard A. Fenske, Ph.D., M.P.H. (Chair), is a Professor and Associate Chair
of Environmental and Occupational Health Sciences at the University of Wash-
ington School of Public Health and Community Medicine, and is the Director
of the Pacific Northwest Agricultural Safety and Health Center at the University
of Washington in Seattle. Dr. Fenske’s work has focused on the evaluation of
environmental health risks in special populations. Specialty areas include health
risks of pesticide exposures, development of new exposure assessment methods,
children’s exposure to hazardous chemicals, and investigation of the role of der-
mal exposure for workers. Dr. Fenske serves on the Science Advisory Board of
the US Environmental Protection Agency, and also serves as a member of EPA’s
Human Studies Review Board. He had previously served on the committees for
Veterans and Agent Orange: Update 2002, Update 2004, and Update 2006.
Erin M. Bell, Ph.D., is Assistant Professor in the Departments of Epidemiology
and Biostatistics and of Environmental Health Sciences at the State University of
New York’s School of Public Health in Albany. She received her undergraduate
degree in biology with honors from Hartwick College and her M.S. and Ph.D.
degrees in epidemiology from the University of Massachusetts, Amherst, and the
University of North Carolina, Chapel Hill, respectively. Between her master’s
and doctoral studies, she was a Research Associate at IOM’s Medical Follow-
up Agency. Her epidemiology research focuses on environmental exposures,
particularly to pesticides, especially as they are related to reproductive, immune,
and cancer outcomes.
Scott W. Burchiel, Ph.D., holds the Nunzio and Sherolyn DeSantis Endowed
Chair in Pharmaco-genomics and is Associate Dean for Research at the Univer-
66
OCR for page 677
6
APPENDIX C
sity of New Mexico (UNM) College of Pharmacy in Albuquerque. He has served
at UNM in numerous capacities since receiving his Ph.D. in pharmacology in
1977 from the University of California at San Francisco School of Medicine.
His continuing research interests include monoclonal antibody production and ra-
diolabeled imaging, lymphocyte activation and signal transduction mechanisms,
and development of biomarkers for immunotoxicity. He has previously served
on NAS committees addressing Beryllium Alloy Exposures and Human Health
Risks of Trichloroethylene and the subcommittee on jet propulsion fuel 8.
Janice Chambers, Ph.D., is a William L. Giles Distinguished Professor and
Director at the Center for Environmental Health Sciences, and Professor at the
Department of Basic Sciences at Mississippi State University. Dr. Chambers
directs several research projects that deal with the effects of pesticides in mam-
malian systems to determine the potential human health effects of pesticide ex-
posures. Specifically, she leads projects related to the metabolism of pesticides
and their neurochemical and behavioral effects in developing organisms to yield
predictions about potential effects of pesticides in infants and children. Her
other projects are involved in developing mathematical predictions of the effects
of mixtures of pesticides on the nervous system so that predictive models can
be generated to potentially describe the effects of future uncharacterized mix-
tures, and the development of more effective antidotes to nerve agent poisoning.
Dr. Chambers has been the principal investigator for numerous federally funded
competitive grants in the field of toxicology. Because of her expertise, she has
been asked to serve on a number of advisory boards and prestigious committees.
Dr. Chambers is board certified as a toxicologist by the American Board of Toxi-
cology and the Academy of Toxicological Sciences. As Director of the Center for
Environmental Health Sciences, she has developed an interdisciplinary research
center specializing in pesticide toxicology and funded primarily by NIH. The
center comprises the areas of neurotoxicology, biochemical toxicology, analytical
chemistry, biostatistics, epidemiology, computational chemistry, computational
simulation, biochemistry, and endocrinology. Dr. Chambers is a member of the
EPA FIFRA Scientific Advisory Panel, the EPA Human Studies Review Board,
and the NCEH/ATSDR Board of Scientific Counselors.
Naihua Duan, Ph.D., M.A., is a Professor of Biostatistics at Columbia Univer-
sity and Director of the Division of Biostatistics at the New York State Psychiatric
Institute in New York City. He received a B.S. in mathematics from National
Taiwan University, an M.A. in mathematical statistics from Columbia University,
and a Ph.D. in statistics from Stanford University. His primary research interest
is study design, particularly for investigations with multilevel data structures.
He previously served on the NAS committees on Advances in Assessing Human
Exposure to Airborne Pollutants, Organ Procurement and Transplantation Policy,
Carbon Monoxide Episodes in Meteorological and Topographical Problem Ar-
OCR for page 678
68 VETERANS AND AGENT ORANGE: UPDATE 2008
eas, and Assessing the Medical Risks of Human Oocyte Donation for Stem Cell
Research.
Peter H. Gann, M.D., Sc.D., is a Professor and Director of Pathology Research
at the University of Illinois at Chicago. A physician-epidemiologist by training,
his research work focuses on the causes of breast and prostate cancer, with par-
ticular emphasis on the development and application of novel biological markers.
His interest in biological markers actually originates with his service as a Project
Director at the National Academy of Sciences in the 1980s. Prior to his current
position, Dr. Gann spent 13 years in the Department of Preventive Medicine
at Northwestern University Medical School. He received a B.A. degree from
Swarthmore College, M.D. and M.S. (epidemiology/biostatistics) degrees from
the University of Pennsylvania, and his doctorate in epidemiology from Harvard
University. Dr. Gann serves on a number of national and international advisory
and peer review panels in the field of cancer prevention. He previously served on
the committee for Veterans and Agent Orange: Update 2006.
Mark S. Goldberg, Ph.D., is a Professor in the Department of Medicine, McGill
University, Montreal, associate member in the Joint Departments of Epidemiol-
ogy and Biostatistics and Occupational Health, the Department of Oncology, and
Medical Scientist, Royal Victoria Hospital, McGill University Health Centre.
Dr. Goldberg is an occupational and environmental epidemiologist and holds an
Investigator Award from the Canadian Institute for Health Research. His current
research interests include the investigation of occupational and environmental
risk factors for breast cancer and the health effects associated with exposures
to ambient air pollution. In addition to being a member of grant review panels,
Dr. Goldberg is also a member of Health Canada’s Science Advisory Board. He
has served on the committee for Disposition of the Air Force Health Study; the
Division of Earth and Life Sciences (DELS) committee for Assessing the Human
Health Risks of Trichloroethylene: Key Scientific Issues; and Veterans and Agent
Orange: Update 2006.
Nancy I. Kerkvliet, Ph.D., is a Professor in the Department of Environmental
and Molecular Toxicology at Oregon State University, Corvallis, Oregon. Dr.
Kerkvliet’s research is focused on using animal models to understand how chemi-
cals of environmental concern alter immune function. Her primary interest is
focused on understanding how activation of the Ah receptor by TCDD and other
ligands suppresses immune responses. She previously served on the Committee
on Toxicology, the Subcommittee of Jet Propulsion Fuel 8, and the committee for
Veterans and Agent Orange: Update 2004 and Update 2006.
Stephen B. Kritchevsky, Ph.D., M.S.P.H., is Professor of Internal Medicine in
the Section on Gerontology and Geriatric Medicine and Director of the J. Paul
OCR for page 679
69
APPENDIX C
Sticht Center on Aging and Rehabilitation at Wake Forest University School of
Medicine in Winston-Salem, NC. After receiving both his M.S.P.H. and Ph.D.
degrees in epidemiology from the University of North Carolina, Chapel Hill, he
joined the Departments of Biostatistics and of Epidemiology at the University of
Tennessee Health Science Center. Dr. Kritchevsky’s research interests are related
to conditions compromising the health of aging populations, particularly inflam-
mation, obesity, metabolic syndrome, and cardiovascular disease.
Michele Marcus, Ph.D., is a Professor in the Departments of Epidemiology and
Environmental and Occupational Health of Emory University in Atlanta. She
is also Director of Graduate studies for the Department of Epidemiology and a
Fellow with the Centers for Disease Control and Prevention. Previously, she was
a faculty member in the Department of Environmental and Occupational Medi-
cine at the Mount Sinai School of Medicine in New York City. She received her
M.P.H., M.Phil., and Ph.D. degrees from Columbia University and her research
interests include environmental and genetic contributions to reproduction and
investigation of the human health effects of endocrine disruptors. She is also a
member of the Southeast Pediatric Environmental Health Specialty Unit.
Linda A. McCauley, Ph.D., FAAN, R.N., is Dean of Emory University’s Nell
Hodgson Woodruff School of Nursing in Atlanta. She was previously the Associ-
ate Dean for Research and the Nightingale Professor in Nursing at the University
of Pennsylvania School of Nursing. Dr. McCauley received her doctoral degree
in environmental health/epidemiology from the University of Cincinnati. Dr.
McCauley has special expertise in the design of epidemiological investigations
of occupational and environmental hazards and is nationally recognized for her
expertise in occupational and environmental health nursing. Dr. McCauley’s re-
search interests are in the areas of chemical exposure among working populations
and young children. Dr. McCauley is a member of the Institute of Medicine. She
previously served on the committees for Veterans and Agent Orange: Update
2006.
Alvaro Puga, Ph.D., is a Professor of Molecular Biology and Environmental
Health, Deputy Director of the NIEHS Center for Environmental Genetics, and
Associate Director of the Superfund Basic Research Program at the University
of Cincinnati Medical Center. Following studies of biology at Universidad de
Madrid, Spain, and of molecular cytogenetics at the University of Lund, Sweden,
he received a Ph.D. in molecular biology and biophysics from Purdue Univer-
sity. Before going to the University of Cincinnati, Dr. Puga served for 15 years
in several capacities at NIH in the Institute of Dental Research and the Institute
of Child Health and Human Development. Study of the AH receptor has been
a major theme of his research. He recently served on the NRC committee that
reviewed EPA’s exposure and human health assessment of dioxin.
OCR for page 680
680 VETERANS AND AGENT ORANGE: UPDATE 2008
Jeremy Shefner, M.D., Ph.D., is a Professor and Chair of Neurology at Upstate
Medical University, and Director of the Clinical Neurophysiology Laboratory
and the MDA/ALS Research and Treatment Center at University Hospital, in
Syracuse, New York. He is trained in neurology and clinical neurophysiology, and
has devoted his clinical and research efforts to ALS. After receiving an M.D. with
distinction from Northwestern University, he completed residency and fellowship
training in neurology and clinical neurophysiology at the Harvard-Longwood
Neurological training program. After fellowship, he joined the faculty at Brigham
and Women’s Hospital and Harvard Medical School. While at the Brigham and
Women’s Hospital, Dr. Shefner directed the ALS Clinic and participated in
multiple industry-sponsored ALS clinical trials. He founded the Northeast ALS
Clinical Trials Consortium in 1995, which has grown to become the largest ALS
clinical trials group in North America. Since moving to Syracuse, he established
the multidisciplinary ALS clinic there, and continues to hold leadership positions
in both industry- and investigator-initiated clinical trials. Dr. Shefner is the recipi-
ent of numerous research grants from NIH and industry sponsors, as well as the
author of more than 100 original research articles and book chapters on neuro-
physiology. Dr. Shefner previously served the IOM Committee on the Review of
Scientific Literature on Amyotrophic Lateral Sclerosis in Veterans.
Hollie I. Swanson, Ph.D., is an Associate Professor in the Department of Mo-
lecular and Biomedical Pharmacology with a joint position with the Toxicology
Department at the University of Kentucky College of Medicine. She received
her M.S. from Oregon State University, Ph.D. from Purdue University, and post-
doctoral training from Michigan State University and Northwestern University.
Her research focuses on the study of the aryl hydrocarbon pathway and its role in
altering cell fate. She currently serves as Councilor of the Drug Metabolism Spe-
cialty Section of the National Chapter of the American Society for Pharmacology
and Experimental Therapeutics, and she is a member of the National and Ohio
Valley Chapters of the Society of Toxicology. She is an editorial board member
of Toxicology and Applied Pharmacology. Dr. Swanson has published numerous
articles pertaining to the molecular and cellular aspects of the AH receptor and
dioxin. She previously served on the committee for Veterans and Agent Orange:
Update 2006.
Staff
Mary Burr Paxton, Ph.D., is a Senior Program Officer in the Institute of Medi-
cine Board on Population Health and Public Health Practice. Before joining IOM,
she worked as a consultant on the regulation of toxic substances and managed
the conduct and analysis of several epidemiology studies on veterans’ health. She
received a master’s of science in biostatistics from the Johns Hopkins School of
Hygiene and Public Health and a doctorate in genetics from the George Wash-
OCR for page 681
681
APPENDIX C
ington University. She is a diplomate of the American Board of Toxicology. Dr.
Paxton has worked on several National Academies reports, including Issues in
Risk Assessment; Enironmental Neurotoxicology; Gulf War and Health: Insec-
ticides and Solents; Gulf War and Health: Fuels, Combustion Products, and
Propellants; Asbestos: Selected Cancers; Veterans and Agent Orange: Update
2004, and Veterans and Agent Orange: Update 2006.
Jennifer A. Cohen, M.P.H., is a Program Officer in the Institute of Medicine
Board on Population Health and Public Health Practice. She has been involved
with the IOM committees that produced Organ Procurement and Transplantation;
Clearing the Air: Asthma and Indoor Air Exposures; Veterans and Agent Orange:
Herbicide/Dioxin Exposure and Type 2 Diabetes; Veterans and Agent Orange:
Update 2000; Veterans and Agent Orange: Herbicide/Dioxin Exposure and Acute
Myelogenous Leukemia in the Children of Vietnam Veterans; Veterans and Agent
Orange: Update 2004; and Veterans and Agent Orange: Update 2006.
Rose Marie Martinez, Sc.D., is Director of the Institute of Medicine Board on
Population Health and Public Health Practice. Before joining the IOM, she was
Senior Health Researcher at Mathematica Policy Research, where she studied
the effects of health-system change on the public-health infrastructure, access to
care for vulnerable populations, managed care, and the health-care workforce.
Dr. Martinez is former Assistant Director for Health Financing and Policy with
the US General Accounting Office, for which she directed evaluations and policy
analysis on national and public-health issues. Dr. Martinez received her doctorate
from the Johns Hopkins School of Hygiene and Public Health.
Tia S. Carter is a Senior Program Assistant in the IOM Board on Population
Health and Public Health Practice. In December 2008, she graduated with her
masters in health-care administration from the University of Maryland Uni-
versity College. She received her undergraduate degree in community health
from the University of Maryland, College Park. Before coming to the IOM, she
worked at the Greater Washington Urban League in the Division of Aging and
Health Services as the Health Promotions Coordinator, where she was responsible
for health-promotion and disease-prevention education services and activities
among the elderly. She has been involved with the IOM committees on Asbestos:
Selected Cancers, Veterans and Agent Orange: Updates 2004, and Veterans and
Agent Orange: Update 2006.
Norman Grossblatt, ELS(D), is a Senior Editor at the National Academies. Be-
fore joining the National Research Council Division of Medical Sciences in 1963,
he worked as an analyst in information storage and retrieval at Documentation
Incorporated and as a technical editor at the Allis-Chalmers Manufacturing Co.,
Nuclear Power Department, in Washington, DC. He received a B.A. in English
OCR for page 682
682 VETERANS AND AGENT ORANGE: UPDATE 2008
from Haverford College. Mr. Grossblatt is a diplomate editor in the life sciences
and was the founding president of the Board of Editors in the Life Sciences. He
is a fellow of the American Medical Writers Association and a recipient of its
President’s Award; a member of the Council of Science Editors and since 1997
the manuscript editor of its journal, Science Editor; and a member of the Euro-
pean Association of Science Editors. At the National Academies, he has edited
over 300 reports.
